Merck (MRK) Current Taxes (2009 - 2026)
Merck's (MRK) quarterly Current Taxes came in at $4.2 billion in Q2 2026, up 1.64% year-over-year from $4.2 billion in Q2 2025, and up 7.05% quarter-over-quarter from $3.9 billion in Q1 2026.
Analysis
Merck (MRK) Current Taxes (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Current Taxes for 18 consecutive years, with $4.2 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Taxes rose 1.64% year-over-year to $4.2 billion in Q2 2026; TTM through Jun 2026 was $4.2 billion, a 1.64% increase from a year earlier, with the FY2025 full-year figure at $4.7 billion, up 20.75% from the prior year.
- Current Taxes was $4.2 billion for Q2 2026 at Merck, up from $3.9 billion in the prior quarter.
- Over five years, Current Taxes peaked at $5.2 billion in Q1 2025 and troughed at $1.4 billion in Q2 2022.
- A 5-year average of $3.1 billion and a median of $2.7 billion in 2023 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes soared 118.58% in 2024 and decreased 23.84% in 2026, its largest moves.
- Over 5 years, Current Taxes stood at $2.0 billion in 2022, then soared by 33.38% to $2.6 billion in 2023, then jumped by 47.75% to $3.9 billion in 2024, then rose by 20.75% to $4.7 billion in 2025, then decreased by 10.62% to $4.2 billion in 2026.
- The last three Current Taxes figures came in at $4.2 billion (Q2 2026), $3.9 billion (Q1 2026), and $4.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.22 Bn |
| Mar 31, 2026 | 3.95 Bn |
| Dec 31, 2025 | 4.73 Bn |
| Sep 30, 2025 | 4.85 Bn |
| Jun 30, 2025 | 4.16 Bn |
| Mar 31, 2025 | 5.18 Bn |
| Dec 31, 2024 | 3.91 Bn |
| Sep 30, 2024 | 4.33 Bn |
| Jun 30, 2024 | 2.78 Bn |
| Mar 31, 2024 | 2.40 Bn |
| Dec 31, 2023 | 2.65 Bn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 1.49 Bn |
| Mar 31, 2023 | 1.87 Bn |
| Dec 31, 2022 | 1.99 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 954.00 Mn |